The China Market-Ready Medtech Workshop will provide CEOs and senior executives of Australian medtech companies knowledge to develop a successful business strategy in China. The one-day workshop will include sessions on developing a market entry strategy, successful partnering approaches, regulatory pathways, distribution and marketing, market risks, common mistakes, and key success factors for Australian medtech products, technologies and services in China.
China market specialists Rob Scott, Director, ChinaBlueSky and Brendan Mason, former General Manager, Cochlear Greater China, will deliver the workshop. Rob and Brendan have between over 20 years combined experience in managing companies and advising clients in the China medtech and biotech space. The program also includes 2 hours of tailored consultation time for companies to confidentially seek advice on market development and key China market questions.
For detailed information about this event please refer to the event brochure (pdf).